Skip to main content

Candesartan Cilexetil and Hydrochlorothiazide

NDC 33342-132 · Macleods Pharmaceuticals Limited

Generic nameCandesartan Cilexetil and Hydrochlorothiazide
Dosage formTABLET
RouteORAL
Active ingredient(s)CANDESARTAN CILEXETIL, HYDROCHLOROTHIAZIDE
Strength32; 12.5 mg/1; mg/1
Pharmacologic classAngiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
Marketing categoryANDA

Packages

33342-132-10 — 90 TABLET in 1 BOTTLE (33342-132-10)

33342-132-12 — 10 BLISTER PACK in 1 CARTON (33342-132-12) / 10 TABLET in 1 BLISTER PACK

33342-132-15 — 500 TABLET in 1 BOTTLE (33342-132-15)

33342-132-51 — 300 TABLET in 1 BOTTLE (33342-132-51)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

33342-074 — Valsartan and Hydrochlorothiazide, 33342-075 — Valsartan and Hydrochlorothiazide, 33342-076 — Valsartan and Hydrochlorothiazide, 33342-077 — Valsartan and Hydrochlorothiazide, 33342-078 — Valsartan and Hydrochlorothiazide, 33342-114 — Candesartan, 33342-115 — Candesartan, 33342-116 — Candesartan, 33342-117 — Candesartan, 33342-131 — Candesartan Cilexetil and Hydrochlorothiazide, 33342-133 — Candesartan Cilexetil and Hydrochlorothiazide, 33342-173 — OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE, 33342-174 — OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE, 33342-175 — OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE, 33342-243 — Olmesartan medoxomil Amlodipine and Hydrochlorothiazide, 33342-244 — Olmesartan medoxomil Amlodipine and Hydrochlorothiazide, 33342-245 — Olmesartan medoxomil Amlodipine and Hydrochlorothiazide, 33342-246 — Olmesartan medoxomil Amlodipine and Hydrochlorothiazide, 33342-247 — Olmesartan medoxomil Amlodipine and Hydrochlorothiazide, 33342-283 — amlodipine,valsartan and hydrochlorothiazide, +890 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels